A detailed history of Searle & Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Searle & Co. holds 84,510 shares of BMY stock, worth $4.87 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
84,510
Previous 94,346 10.43%
Holding current value
$4.87 Million
Previous $3.92 Million 11.61%
% of portfolio
1.11%
Previous 0.92%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $390,095 - $509,013
-9,836 Reduced 10.43%
84,510 $4.37 Million
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $71,041 - $93,527
1,765 Added 1.91%
94,346 $3.92 Million
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $551,770 - $625,600
-11,500 Reduced 11.05%
92,581 $5.02 Million
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $535,607 - $639,126
11,048 Added 11.88%
104,081 $5.34 Million
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $6,425 - $7,185
-111 Reduced 0.12%
93,033 $5.4 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $7,135 - $7,922
-112 Reduced 0.12%
93,144 $5.96 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $6,148 - $7,372
100 Added 0.11%
93,256 $6.81 Million
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $21,452 - $25,008
-400 Reduced 0.43%
93,156 $5.81 Million
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $24,082 - $26,226
389 Added 0.42%
93,556 $6.25 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $92,384 - $104,688
1,600 Added 1.75%
93,167 $5.78 Million
Q3 2019

Oct 22, 2019

BUY
$42.77 - $50.71 $78,440 - $93,002
1,834 Added 2.04%
91,567 $4.64 Million
Q2 2019

Jul 17, 2019

SELL
$44.62 - $49.34 $14,144 - $15,640
-317 Reduced 0.35%
89,733 $4.07 Million
Q1 2019

Apr 22, 2019

SELL
$45.12 - $53.8 $24,725 - $29,482
-548 Reduced 0.6%
90,050 $4.3 Million
Q3 2018

Oct 16, 2018

SELL
$55.19 - $62.25 $4,967 - $5,602
-90 Reduced 0.1%
90,598 $5.62 Million
Q2 2018

Jul 19, 2018

BUY
$50.53 - $62.98 $50,530 - $62,980
1,000 Added 1.11%
90,688 $5.02 Million
Q1 2018

Apr 25, 2018

BUY
$59.92 - $68.98 $29,960 - $34,490
500 Added 0.56%
89,688 $5.67 Million
Q4 2017

Jan 17, 2018

SELL
$59.94 - $65.35 $6,713 - $7,319
-112 Reduced 0.13%
89,188 $5.47 Million
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $4.93 Million - $5.69 Million
89,300
89,300 $5.69 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Searle & Co. Portfolio

Follow Searle & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.